source
- Ibrutinib Monotherapy Yields Decade-Long Durable Efficacy in Across CLL SubtypesIbrutinib monotherapy produced durable efficacy over 10 years in patients with or without TP53-mutated chronic lymphocytic leukemia.onclive · 2mo ago↗ source
- #ASGCT26: Encoded's gene therapy reduced seizures in Dravet syndromeA gene therapy designed by Encoded Therapeutics reduced seizures by 76% in children with Dravet syndrome, a severe neurodevelopmental disorder. The remarkable reduction was observed only in three p…Endpoints · 2mo ago↗ source
- STAT investigates the epidemic killing 178,000 Americans a yearRead Executive Editor Rick Berke's letter to STAT readers on "The Deadliest Drug," a new investigative series into the country's failure to address excessive alcohol use.